JP2015503918A5 - - Google Patents

Download PDF

Info

Publication number
JP2015503918A5
JP2015503918A5 JP2014550544A JP2014550544A JP2015503918A5 JP 2015503918 A5 JP2015503918 A5 JP 2015503918A5 JP 2014550544 A JP2014550544 A JP 2014550544A JP 2014550544 A JP2014550544 A JP 2014550544A JP 2015503918 A5 JP2015503918 A5 JP 2015503918A5
Authority
JP
Japan
Prior art keywords
patent document
international
cell
january
literature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014550544A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015503918A (ja
JP6548897B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/072331 external-priority patent/WO2013102219A1/en
Publication of JP2015503918A publication Critical patent/JP2015503918A/ja
Publication of JP2015503918A5 publication Critical patent/JP2015503918A5/ja
Application granted granted Critical
Publication of JP6548897B2 publication Critical patent/JP6548897B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014550544A 2011-12-30 2012-12-31 同種異系細胞の医療用途の誘導のための方法及び組成物並びに治療的利用 Active JP6548897B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161582070P 2011-12-30 2011-12-30
US61/582,070 2011-12-30
US201261591211P 2012-01-26 2012-01-26
US61/591,211 2012-01-26
PCT/US2012/072331 WO2013102219A1 (en) 2011-12-30 2012-12-31 Methods and compositions for the clinical derivation of an allogenic cell and therapeutic uses

Publications (3)

Publication Number Publication Date
JP2015503918A JP2015503918A (ja) 2015-02-05
JP2015503918A5 true JP2015503918A5 (enExample) 2016-02-18
JP6548897B2 JP6548897B2 (ja) 2019-07-24

Family

ID=48698707

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014550544A Active JP6548897B2 (ja) 2011-12-30 2012-12-31 同種異系細胞の医療用途の誘導のための方法及び組成物並びに治療的利用

Country Status (12)

Country Link
US (8) US9803176B2 (enExample)
EP (2) EP3321355B1 (enExample)
JP (1) JP6548897B2 (enExample)
CA (2) CA2862661C (enExample)
DK (1) DK3321355T3 (enExample)
ES (2) ES2656614T3 (enExample)
HR (1) HRP20211373T1 (enExample)
HU (1) HUE056817T2 (enExample)
PL (1) PL3321355T3 (enExample)
PT (1) PT3321355T (enExample)
SI (1) SI3321355T1 (enExample)
WO (1) WO2013102219A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2999420A1 (en) 2005-09-27 2007-04-05 Tissuetech, Inc. Amniotic membrane preparations and purified compositions and methods of use
WO2012149486A1 (en) 2011-04-28 2012-11-01 Tissuetech, Inc. Methods of modulating bone remodeling
EP2717888B1 (en) 2011-06-10 2020-09-09 Tissuetech, Inc. Methods of processing fetal support tissues
US10167448B2 (en) 2013-12-12 2019-01-01 Samsung Life Public Welfare Foundation Pharmaceutical composition for treating cerebrovascular diseases, containing stem cell-derived exosome as active ingredient
KR101661847B1 (ko) 2014-03-18 2016-09-30 사회복지법인 삼성생명공익재단 줄기세포 유래 엑소좀을 유효성분으로 포함하는 뇌 염증성 질환의 치료용 조성물
WO2015179711A1 (en) * 2014-05-21 2015-11-26 Mimedx Group, Inc. Micronized wharton's jelly
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
JP6640826B2 (ja) 2014-07-08 2020-02-05 ミメディクス グループ インコーポレイテッド 微粒子化ワルトン膠質
WO2016138025A2 (en) 2015-02-23 2016-09-01 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
TWI720984B (zh) 2015-05-20 2021-03-11 美商帝聖工業公司 用於防止上皮細胞增生及上皮-間質轉移之組合物及方法
ES2914692T3 (es) * 2015-08-12 2022-06-15 Cha Biotech Co Ltd Células madre adhesivas derivadas de cordón umbilical mejoradas, método de preparación para las mismas, y uso de las mismas
US12551509B2 (en) 2015-11-18 2026-02-17 Lucina Patent Holdco, Llc Acellular regenerative products and methods of their manufacture
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
EP3474869B1 (en) * 2016-06-24 2025-04-09 Osiris Therapeutics, Inc. Human tissue derived compositions and uses thereof
US11649436B2 (en) 2016-12-02 2023-05-16 The Catholic University Of Korea Industry-Academic Cooperation Foundation Exosome for stimulating T cell and pharmaceutical use thereof
KR101864234B1 (ko) * 2017-07-04 2018-06-04 인하대학교 산학협력단 음경해면체 유래 엑소좀을 유효성분으로 포함하는, 발기부전 예방, 개선 또는 치료용 조성물
US11285177B2 (en) 2018-01-03 2022-03-29 Globus Medical, Inc. Allografts containing viable cells and methods thereof
CN108239621B (zh) * 2018-01-24 2020-08-18 北京臻溪谷医学研究中心(有限合伙) 一种胎盘亚全能干细胞分离、扩增、冻存、复苏干细胞的方法
WO2020150310A1 (en) * 2019-01-16 2020-07-23 University Of Utah Research Foundation Use of mesenchymal stem cell sheets for preventing uterine scar formation
EP3911344A4 (en) 2019-01-16 2022-10-19 University of Utah Research Foundation MESENCHYMAL STEM CELL LAYERS FROM HUMAN UMBILICAL CORD AND PROCESS FOR THEIR PRODUCTION
MX2023002726A (es) * 2020-09-08 2023-05-18 Amit Patel Citoblastos alogenicos de cordón umbilical para el tratamiento de condiciones respiratorias graves.
US20230057957A1 (en) * 2021-08-23 2023-02-23 Therapeutic Solutions International, Inc. Umbilical cord mesenchymal stem cells for treatment of chronic obstructive pulmonary disease and lung degeneration
US20230295569A1 (en) * 2022-03-15 2023-09-21 Creative Medical Technologies, Inc. Therapeutic regenerative cells
US20230293598A1 (en) * 2022-03-15 2023-09-21 Narkeshyo LLC Prevention of radiation exposure associated pathology by treatment with umbilical cord derived regenerative cells
US20230364148A1 (en) * 2022-05-12 2023-11-16 Therapeutic Solutions International, Inc. Inhibition and reversion of chronic obstructive pulmonary disease (copd) by endothelial cell regeneration
CN119452078A (zh) * 2022-06-29 2025-02-14 富士胶片控股美国公司 Ipsc来源的星形胶质细胞及其使用方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
AU4221399A (en) 1998-05-29 1999-12-13 Osiris Therapeutics, Inc. Human cd45+ and/or fibroblast + mesenchymal stem cells
US20030161818A1 (en) 2002-02-25 2003-08-28 Kansas State University Research Foundation Cultures, products and methods using stem cells
WO2004072273A1 (en) 2003-02-11 2004-08-26 Davies John E Progenitor cells from wharton's jelly of human umbilical cord
WO2005001080A2 (en) 2003-06-27 2005-01-06 Ethicon, Incorporated Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
PL1789534T3 (pl) 2004-08-16 2015-03-31 Cellresearch Corp Pte Ltd Wyodrębnienie komórek macierzystych/progenitorowych z błony owodniowej pępowiny
WO2007106089A1 (en) 2006-03-14 2007-09-20 Spherical Dynamics, Inc. System for and method for psychological assessment
EP3763376A1 (en) * 2007-02-12 2021-01-13 Celularity, Inc. Treatment of inflammatory diseases using placental stem cells
PT103843B (pt) 2007-10-04 2008-08-12 Medinfar Produtos Farmaceutico Método de isolamento de células precursoras a partir do cordão umbilical humano
NZ592839A (en) * 2008-11-21 2012-10-26 Anthrogenesis Corp Treatment of diseases, disorders or conditions of the lung using placental cells
CN101748096B (zh) * 2008-12-17 2013-03-13 北京汉氏联合生物技术有限公司 亚全能干细胞、其制备方法及其用途
CA2756670A1 (en) 2009-03-26 2010-09-30 The Regents Of The University Of California Mesenchymal stem cells producing inhibitory rna for disease modification
EP2483392B1 (en) 2009-09-23 2015-11-11 Davinci Biosciences LLC Umbilical cord lining stem cells and methods and material for isolating and culturing same
CN101890050B (zh) * 2010-07-14 2012-07-04 江苏大学 脐带间质干细胞来源膜性囊泡及其应用
EP2540819A1 (en) 2011-06-27 2013-01-02 Rheinisch-Westfälische Technische Hochschule Aachen (RWTH) Method for cultivating cells in platelet-lysate-containing medium
US20210355437A1 (en) 2015-09-02 2021-11-18 Restem Llc Factor rich product from umbilical cord mesenchymal stem cells

Similar Documents

Publication Publication Date Title
JP2015503918A5 (enExample)
MY177970A (en) Bcma (cd269/tnfrsf17) -binding proteins
BR112013012555A2 (pt) peptídeos imunogênicos para o uso na prevenção e/ou no tratamento de doenças infecciosas, doenças autoimunes, respostas imunes a alofatores, doenças alérgicas, tumores, rejeição a enxertos e respostas imunes contra vetores virais usados para a terapia de genes ou na vacinação de genes
IL255752B (en) Compounds, pharmaceutical compositions comprising the same and uses thereof for treating cardiovasclar disease, an inflammatory disease or cancer
CY1121310T1 (el) Χρηση πυριτικου ζιρκονιου για τη θεραπεια της υπερκαλιαιμιας
JP2013517798A5 (enExample)
EA201270713A1 (ru) Белки на основе фибронектина с каркасными доменами, которые связывают ил-23
UY29653A1 (es) Nuevos anticuerpos anti-madcam
WO2013185112A8 (en) Pharmaceutical compositions for the treatment of cftr -mediated disorders
EA201590833A1 (ru) Антитела для лечения и профилактики болезни альцгеймера и их применение
MX2010003574A (es) Anticuerpos il-23.
EP2987807A3 (en) Antibodies recognising phospho-tau
DK2276485T3 (da) Anvendelse af epothilon d i behandling af tau-associerede sygdomme,herunder alzheimers sygdom
UA113609C2 (xx) Антигензв'язуючий білок, який зв'язує людський il-23
EA201390682A1 (ru) Спирооксиндольные антагонисты mdm2
CL2007002274A1 (es) Compuestos derivados del acido (3-amino-1,2,3,4-tetrahidro-9h-carbazol-9-il)-acetico; composicion farmaceutica; y uso para la prevencion y/o tratamiento de enfermedades alergicas e inmunes, tales como asma, epoc y rinitis entre otras.
MX360684B (es) Silicato de zirconio microporoso para el tratamiento de la hipercalemia.
IN2015DN02729A (enExample)
AR079114A1 (es) Proteinas de enlace de antigenos anti-orai1 y usos de las mismas
WO2012083302A3 (en) Compositions and methods for the treatment or prevention of human adenovirus-36 infection
IT1405793B1 (it) Molecola di u1snrna umano modificato, gene codificante per la molecola di u1snrna umano modificato, vettore di espressione includente il gene, e loro uso in terapia genica
BR112014011981A2 (pt) formulações farmacêuticas
EA201491513A1 (ru) Рекомбинантные штаммы escherichia coli
EP2187898B8 (en) Use of viral vectors carrying the cyp46a1 gene for the treatment of alzheimer's disease
EA201690659A1 (ru) Композиции аморфного магнийзамещенного фосфата кальция и их применение